Kamala International Exim

4 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• UNSAFE COL2 refused lines

  Color additive unsafe under section 721

  The product appeared to be, or to contain, a color additive that is unsafe within the meaning of section 721(a) of the FD&C Act, the section that governs which color additives may be used and how.

• FALSE1 refused line

  False or misleading labeling

  The labeling appeared to be false or misleading in some particular.

• HEALTH C1 refused line

  Unauthorized nutrient content or health claim

  The label or labeling appeared to carry a nutrient content claim or health claim that is not authorized.

• NUTRIT LBL1 refused line

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

Questions about Kamala International Exim

Is Kamala International Exim on an FDA import alert?

Yes. As of October 26, 2026, Kamala International Exim is on the red list of FDA Import Alert 99-39, “Imported foods that appear to be misbranded”, for "king dutch" wafer rolls; hazelnut flavor; FDA published the listing on May 22, 2017.

Has FDA refused shipments from Kamala International Exim?

Yes. FDA refused 2 shipment lines from Kamala International Exim between March 14, 2017 and January 29, 2018. The most recent, on January 29, 2018, was nut plain cookies,biscuits and wafers, charged as UNSAFE COL (color additive unsafe under section 721).

Why did FDA refuse Kamala International Exim's shipments?

The most frequent charges are UNSAFE COL (color additive unsafe under section 721, 2 lines) and FALSE (false or misleading labeling, 1 line).

What is Kamala International Exim's FEI number?

Kamala International Exim's FDA Establishment Identifier (FEI) is 3009674970.

Can shipments from Kamala International Exim still enter the U.S.?

Shipments of "king dutch" wafer rolls; hazelnut flavor from Kamala International Exim can be detained without physical examination under Import Alert 99-39; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).